Publications

5808 Results

The Influence of Age on Patient-Reported Outcomes (PROs) Endpoints on the S1826 Cross-Network Phase III trial of Advanced-Stage, Classic Hodgkin Lymphoma (cHL) (3891/4500)

Authors
K Davison;J Unger;H Li;S Castellino;H Dillon;T Hernandez;S Rutherford;A Punnett;M LeBlanc;J Song;S Smith;A Evens;K Kelly;J Friedberg;A Herrera;S Parsons
Journal / Conference
ASH Annual Meeting (December 6-9, 2025, Orlando, FL). poster abstract 2738. Blood (2025) 146 (Supplement 1): 2738
Year
2025
Research Committee(s)
Lymphoma
Study Number(s)
S1826

Randomized Phase 2/3 Study of Conventional Chemotherapy +/- Uproleselan in Older Adults with Acute Myeloid Leukemia (AML) Receiving Intensive Induction Chemotherapy (Alliance A041701)

Authors
G Uy;J Yin;S Dinner;D DeAngelo;J Liesveld;J Kolitz;A Asch;O Odenike;O Kour;R Teske;K Skogen;K Byrd;R Little;A Carroll;K Mrozek;A Eisfeld;J Byrd;A Jaslowski;H Erba;M Litzow;W Stock;R Stone
Journal / Conference
ASH Annual Meeting (December 6-9, 2025, Orlando, FL). poster. Blood (2025) 146 (Supplement 1): 3415. doi: 10.1182/blood-2025-3415
Year
2025
Research Committee(s)
Leukemia

Biallelic TP53 aberrations and double TP53 mutations are prevalent in AML/MDS patients with del(5q) complex karyotype - An NCI myeloMATCH and SWOG Report

Authors
M Fang;K Kroeger;T Nguyen;X Qu;C Yeung;S Jiwani;B Wood;L Harris;H Erba;M Othus;J Radich;R Little
Journal / Conference
ASH Annual Meeting (December 6-9, 2025, Orlando, FL). Abstract 5276 poster. Blood (2025) 146 (Supplement 1): 5276
Year
2025
Research Committee(s)
Leukemia
Study Number(s)
MM1YA-S01

Improving Karyotype Success for myeloMATCH: Evidence-Based Culturing Optimization for Rapid AML Screening - An NCI myeloMATCH and SWOG Report

Authors
X Qu;S Mcclung;N Shepherd;K Kroeger;B Hale;M Othus;H Erba;L Harris;R Little;J Radich;M Fang
Journal / Conference
ASH Annual Meeting (December 6-9, 2025, Orlando, FL). Abstract 3473 poster. Blood (2025) 146 (Supplement 1): 3473
Year
2025
Research Committee(s)
Leukemia
Study Number(s)
MM1YA-S01

RADIOTHERAPY PATTERNS OF CARE IN PATIENTS WITH NODAL MICROMETASTASES: A SECONDARY SUBGROUP ANALYSIS OF SWOG 1007

Authors
J Bazan;A Meisner;K Kalinsky;E Connolly;W Barlow;W Woodward;A Thompson;P Sharma;L Pusztai;R Jagsi
Journal / Conference
San Antonio Breast Cancer Symposium (December 9-12, 2025, San Antonio, TX)
Year
2025
Research Committee(s)
Breast
Study Number(s)
S1007

3-Year Follow-up of the S1826 Study Confirms Improved Progression-Free Survival with Nivolumab-AVD Compared to Brentuximab Vedotin-AVD in Advanced Stage Classic Hodgkin Lymphoma

Authors
A Herrera;M LeBlanc;S Castellino;H Li;S Rutherford;A Evens;K Davison;A Punnett;S Parsons;S Ahmed;C Casulo;N Bartlett;J Tuscano;M Mei;B Hess;R Jacobs;B Hu;C Moskowitz;C Forlenza;A Doan;A Lamble;D Hodgson;M Knopp;P Hernandez;R Little;M Shipp;RM Crump;B Kahl;JP Leonard;S Smith;J Song;K Kelly;J Friedberg
Journal / Conference
ASH Annual Meeting (December 6-9, 2025, Orlando, FL). #151 oral. Blood (2025) 146 (Supplement 1): 151.
Year
2025
Research Committee(s)
Lymphoma
Study Number(s)
S1826

MyeloMATCH: Successful screening and clinical-pathologic features of the first 550 patients

Authors
E Winer;M Othus;E Atallah;S Tsai;M Sabloff;A Osman;A Im;S Loghavi;A Moseley;J Shahanawaz;B Wood;M Fang;C Yeung;X Chen;X Qu;S Ghatak;S Gore;G Uy;L Michaelis;T Odenike;R Stone;S Lugar;S Assouline;H Erba;M Litzgow;C Lachowiez;J Reagan;U Borate;L Savoie;B Jonas;N Roy;J Radich;R Little
Journal / Conference
ASH Annual Meeting (December 6-9, 2025, Orlando, FL). #5279 poster. Blood (2025) 146 (Supplement 1): 5279.
Year
2025
Research Committee(s)
Leukemia
Study Number(s)
MYELOMATCH

CtDNA Analyses of Molecular Tumor Burden Improve Response Assessment in Patients with Advanced Stage Classic Hodgkin Lymphoma Treated on SWOG S1826

Authors
J Paczkowska;M Kaszkowiak;M LeBlanc;C Stewart;A Herrera;J Fernandez del Castillo;S Castellino;S Rutherford;A Evens;K Davison;H Li;D Neuberg;M Murakami;J Makker;B Kahl;J Leonard;N Bartlett;S Smith;J Song;K Kelly;G Getz;JW Friedberg;M Shipp
Journal / Conference
ASH Annual Meeting (December 6-9, 2025, Orlando, FL). oral #351. Blood (2025) 146 (Supplement 1): 351. 10.1182/blood-2025-351
Year
2025
Research Committee(s)
Lymphoma
Study Number(s)
S1826

Clinical Trial Availability and Receipt of Guideline Concordant Care among Adolescents and Young Adults (AYAs) with Acute Lymphoblastic Leukemia

Authors
J Wolfson;M Nuno;A Grimes;A Keckley;M Roth;M Beauchemin;S Ramakrishnan;D Dickens;W Woods;K Barnett;T Alabi;J Levine;M Scialla;K Boayue;O Ponce;S Vargas;G Chang;W Stock;D Hershman;E Curran;A Advani;K O'Dwyer;S Luger;J Liu;D Freyer;L Song;S Parsons
Journal / Conference
ASH Annual Meeting (December 6-9, 2025, Orlando, FL). poster abstract 6190. Blood (2025) 146 (Supplement 1): 6190
Year
2025
Research Committee(s)
Cancer Care Delivery

Prognostic impact of mantle cell lymphoma frontline induction response assessments in the ECOG-ACRIN E1411 study of bendamustine-rituximab +/- bortezomib and maintenance with rituximab +/- lenalidomide

Authors
C Ryan;V Wang;M Smith;B Till;S Parekh;D Yang;L Kostakoglu Shields;N Samad;O Jegede;R Little;J Friedberg;J Leonard;B Kahl;P Martin
Journal / Conference
ASH Annual Meeting (December 6-9, 2025, Orlando, FL). Abstract 3581 poster. Blood (2025) 146 (Supplement 1): 3581
Year
2025
Research Committee(s)
Lymphoma
Study Number(s)
CTSU/E1411